You have 9 free searches left this month | for more free features.

RP11

Showing 1 - 25 of 4,413

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

Recruiting
  • Retinal Dystrophy
  • +2 more
  • Dallas, Texas
    Retina Foundation of the Southwest
Jun 5, 2023

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting
  • Retinitis Pigmentosa
  • +4 more
    • San Francisco, California
    • +4 more
    Oct 5, 2022

    High-risk Prostate Cancer, Prostate Cancer, Prostate Cancer Metastatic Trial in Austria, Germany (Ga-68-PSMA-11)

    Completed
    • High-risk Prostate Cancer
    • +3 more
    • Innsbruck, Austria
    • +7 more
    Jul 24, 2020

    Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Brewer, Maine
    • +8 more
    Jun 18, 2021

    High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

    Recruiting
    • High Risk Neuroblastoma
    • +2 more
    • Dinutuximab
    • +4 more
    • Birmingham, Alabama
    • +141 more
    Dec 28, 2022

    Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Trial in Rochester (drug, radiation, other, biological, procedure)

    Completed
    • Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
    • Rochester, Minnesota
      Mayo Clinic
    Mar 16, 2020

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

    Recruiting
    • Danon Disease
    • RP-A501
    • La Jolla, California
    • +1 more
    Oct 17, 2023

    Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Fairfax, Virginia
      NEXT Oncology
    Jun 7, 2023

    Triple Negative Breast Tumors Trial in Worldwide (Atezolizumab, Placebo, Gemcitabine)

    Recruiting
    • Triple Negative Breast Neoplasms
    • Fort Myers, Florida
    • +165 more
    Jan 12, 2023

    Solid Tumor Trial in Beijing (GLS-012, GLS-010)

    Recruiting
    • Solid Tumor
    • Beijing, China
      Beijing Cancer Hospital
    Jun 11, 2023

    Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

    Completed
    • Retinitis Pigmentosa
    • Wharton's jelly derived mesenchymal stemcells
    • Magnovision
    • Ankara, Gölbaşı, Turkey
    • +2 more
    Mar 23, 2023

    Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

    Not yet recruiting
    • Locally Advanced Unresectable Pancreatic Adenocarcinoma
    • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
    • (no location specified)
    Jun 25, 2023

    Deep Brain Stimulation, Parkinson Disease Trial in Shanghai (remote programming, standard programming)

    Not yet recruiting
    • Deep Brain Stimulation
    • Parkinson Disease
    • remote programming
    • standard programming
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Oct 8, 2023

    Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

    Recruiting
    • Head and Neck Carcinoma
    • Adult Disease
    • HPVDC injection level dose 1
    • +3 more
    • Villejuif, France
      Gustave Roussy
    Aug 17, 2023

    Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

    Recruiting
    • Multiple Myeloma (MM)
    • +5 more
    • Santander, Cantabria, Spain
    • +4 more
    Jun 19, 2023

    Dexamethasone Associated With Axillary Plexus on Occurrence of

    Not yet recruiting
    • Adjuvants, Anesthesia
    • Brachial Plexus Anesthesia
    • upper extremity bone surgery
    • (no location specified)
    Mar 8, 2023